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Influence of sulfur containing di-amino acid structure 
on covalently crosslinked copolypeptide hydrogels 
Eric D. Raftery,[b] Eric G. Gharkhanian,[b] Nicole G. Ricapito,[c] J. McNamara,[c] and Timothy J. 
Deming*[a]
 
Abstract: Biologically occurring
non-canonical di--amino acids were converted into new di-
N-carboxyanhydride  (di-NCA)  monomers  in  reasonable
yields  with  high  purity.  Five  different di-NCAs  were
separately  copolymerized  with  tert-butyl-L-glutamate  NCA
to obtain covalently crosslinked copolypeptides capable of
forming  hydrogels  with  varying  crosslinker  density.
Comparison  of  hydrogel  properties  with  residue structure
revealed that different di--amino acids were not equivalent
in  crosslink  formation.  Notably,  L-cystine  was  found  to
produce  significantly  weaker  hydrogels  compared  to  L-
homocystine, L-cystathionine, and L-lanthionine, suggesting
that L-cystine may be a sub-optimal  choice of di--amino
acid  for  preparation of  copolypeptide  networks.  The di--
amino  acid  crosslinkers  also  provided  different  chemical
stability,  where disulfide crosslinks were readily degraded
by reduction, and thioether crosslinks were stable against
reduction. This difference in response may provide a means
to  fine  tune  the  reduction  sensitivity  of  polypeptide
biomaterial networks. 
Introduction
 Novel hydrogel networks are continuously investigated
for their potential to fulfill unmet needs in drug delivery,
wound healing, and tissue engineering applications [1].
Hydrogels,  cross-linked  polymer  systems  that  swell  in
aqueous environments, are useful biomedical materials
that can be biocompatible and possess several tunable
properties (e.g. cross-link density, pore size, degradation
rate,  etc.).  One  of  the  most  important  factors  for
successfully achieving a desired performance property is
the  rational  selection  of  constituent  molecules  from
which  the  hydrogel  network  is  prepared.  To  date,  a
number of natural (e.g. collagen, hyaluronan, cellulose,
etc.) and synthetic polymers (e.g. poly(ethylene glycol),
poly(acrylamide),  poly(vinyl  alcohol),  etc.)  have  been
utilized  in  hydrogels  for  various  purposes  [2].  In  the
present study, we highlight the potential to synthesize
new  hydrogel  networks  with  advantageous
functionalities through the use of previously unexplored
bio-based  compounds  as  starting  monomers  for
polymerization. 
Molecules  that  are  known  to  exist  within  living
organisms  are  often  multi-functional  and  chiral.  The
unique  characteristics  of  such  molecules  enable
polymerization  into  various  form  factors  with  tunable
features  such  as  3D  structure,  biodegradability,  and
biomimetic  rheological  properties  [2].  Additionally,  the
presence  of  multiple  functional  groups  offers  reactive
sites  for  chemical  cross-linking,  drug  or  cell
attachments,  and  surface  property  alterations.  Amino
acids  are  one  such  class  of  compounds  that  are
frequently  investigated  for  use  in  biomedical
applications  [3].  Natural  amino  acids  are  attractive
building blocks, as they offer an array of functionalities
that  can  be  inserted  into  homo-  and  co-polymeric
systems through the use of straightforward and scalable
N-carboxyanhydride (NCA)-based polymerization [3].
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Figure 1. Chemical structures of di--amino acids used to prepare
di-NCA chemical crosslinkers. 
While many of the 20 standard amino acids have been
utilized  in  biomimetic  materials  [3],  the  realm  of
possibilities in -amino acid based technologies extends
beyond  these  common  moieties.  A  number  of  non-
translated  amino  acids  are  known  to  exist  in  living
systems and recent advances in microbial engineering
strategies  may  allow  for  cost-effective  production  of
these non-canonical amino acids in large quantities [4].
The  integration  of  high  throughput  technologies,
machine  learning,  and  advanced  genomics  offers  the
potential to increase the ease with which biomolecules
can be  produced through  fermentation  in  high  yields,
and  at  low  costs,  particularly  compared  to  synthetic
routes  [5].  In  the  present  work,  we  focus  on  the
exploration of a sub-class of compounds in this category:
di--amino acids (Figure 1).  If found to be valuable for
materials  applications,  these  di--amino  acids have
potential  to  be  practical  feedstocks  for  downstream
applications. 
The  use  of  di--amino  acids for  the  synthesis  of
covalently  crosslinked  polypeptides  dates  back  to  the
early 1950s, when the di-N-carboxyanhydride, di-NCA, of
L-cystine  was  first  prepared  and  subsequently
homopolymerized  to  produce an intractable solid  that
could  be  solubilized  by  reduction  with  2-
mercaptoethanol  [6].   Copolymerization  of  D/L-cystine
di-NCA with NCAs of  L-lysine and L-glutamic acid  was
also reported, which yielded water insoluble, crosslinked
solids  presumably  containing  both  covalent  and  ionic
crosslinks [7]. These materials were found to reversibly
swell in either acidic (pH < 5) or basic media (pH > 10),
which would be expected to disrupt ionic crosslinks via
neutralization  of  glutamate  or  lysine  side-chains,
respectively. 
In  more  recent  usage,  L-cystine  di-NCA  has  been
incorporated  into  covalently  crosslinked  polypeptide
containing nanogels or star particles. In these systems,
linear  polymer chains,  typically either  PEG [8],  poly-L-
lysine  [9],  or  poly-L-glutamate  [10]  with  free  amine
groups on their chain ends were reacted with L-cystine
di-NCA with or without additional NCA monomers to give
covalently crosslinked nanoparticles. The resulting water
soluble  particles  offer  attractive  properties  for  drug
delivery since they can be either swollen or dissolved by
reduction of the cystine disulfide bond crosslinks [8-10].
The  ability  to  degrade  a  cross-linked  system  in  a
controlled manner through exposure to a trigger, such
as a reducing agent, is an area of high interest in the
development  of  stimuli-responsive  materials.  For
example,  disulfide  based  technologies  are  often
investigated  for  the  targeted  intracellular  release  of
therapeutics owing to increased levels of the reducing
agent  glutathione  in  the  cytosol  compared  to  the
bloodstream [8-10]. 
An important observation from previous polymerizations
of  L-cystine  di-NCA  was  that  consumption  of  this
monomer  during  polymerization  was  typically
incomplete, stopping around 70 to 80% conversion [8-
10]. This result may be due to the inability of polymer
bound NCA groups from single additions of L-cystine di-
NCA to  find  and  react  with  growing  chain  ends  once
networks  are  formed.  In  the  nanoparticle  systems
described  above,  the  unreacted  cystine  NCA  groups
were  beneficially  utilized  for  attachment  of  functional
amines to tune nanoparticle properties [8-10]. However,
lack of complete polymerization hints that L-cystine di-
NCA  may  not  fully  incorporate  during  copolypeptide
synthesis. 
Here, we sought to explore the potential for preparation
of  covalently  crosslinked  copolypeptide  hydrogels  via
copolymerization  of  di-NCA  monomers  and  a
monofunctional  NCA.  In  particular,  due  to  potential
issues  observed  with  incomplete  incorporation  of  L-
cystine di-NCA during copolymerizations, as well as the
limited  availability  of  alternative  di-NCA  molecules  to
evaluate structure-property relationships, we sought to
develop and incorporate other natural  di--amino acids
as  comonomers  for  hydrogel  preparation.  More
specifically, we aimed to expand the palette of di-NCA
monomers toward the goal of tuning hydrogel properties
including their sensitivity to reduction and oxidation. We
selected the set of  di--amino acids shown in Figure 1
since  they  allow  evaluation  of  copolymerization  and
hydrogel  formation  with  different  linker  segment
lengths,  and  also  utilize  both  reducible  (i.e.  disulfide)
and non-reducible (i.e. thioether) tethers. In this study,
we  prepared  di-NCA  monomers  for  all  the  di--amino
acids shown  in  Figure  1  (Figure  2),  and  individually
investigated  their  copolymerization  with  tert-butyl-L-
glutamate  NCA  (Bu-Glu  NCA)  to  prepare  covalently
crosslinked  copolypeptide  hydrogels.  Subsequent
comparison of hydrogel properties with residue structure
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was used to evaluate the potential of each  di--amino
acid to act as a crosslinker. The ability of each hydrogel
to  respond  to  chemical  reduction  stimulus  was  also
evaluated.
Figure 2. Structures of di-NCAs 1a-1e.
Results and Discussion
In  order  to  study  the  potential  of  di--amino acids in
Figure  1  for  formation  of  crosslinked  copolypeptide
hydrogels,  many  di--amino  acids and  new  di-NCAs
needed to be prepared.  Of the molecules in Figure 2,
only L-cystine di-NCA has been previously reported [6].
Since L-cystine is readily available, it can be converted
to  the  di-NCA  via  direct  reaction  with  phosgene  or  a
phosgene equivalent  such as triphosgene.  Due to  the
low solubility of  L-cystine in the reaction mixture,  low
yields  of  L-cystine  di-NCA  (1a)  have  typically  been
reported (ca. 20-25%, isolated and purified) [6,8]. Higher
yields have been reported with use of a more soluble
precursor  for  this  reaction,  such  as  N,N'-
bis(benzyloxycarbonyl)-L-cystine,  at  the  expense  of
reduced atom economy [9,10].  Since L-homocystine is
also  commercially  available,  we  prepared  its
corresponding  di-NCA  (1b)  by  direct  reaction  with
triphosgene.  Due  to  the  greater  solubility  of  L-
homocystine versus L-cystine in THF, a reasonable yield
of new di-NCA  1b was obtained (ca. 42%, isolated and
purified). 
Scheme 1. Preparation of di-NCA monomer 1d.
Due  to  their  limited  commercial  availability  and  high
cost,  the remaining  di--amino acids in Figure 1 were
prepared using chemical synthesis. L-Cystathionine was
prepared  from  L-homocysteine  thiolactone  and  L-
chloroalanine  via  a  modified  literature  procedure  as
shown in Scheme 1 [11]. This product was subsequently
phosgenated to obtain the new L-cystathionine di-NCA
(1d) in reasonable yield (ca. 54%, isolated and purified).
L-Lanthionine  and  L-homolanthionine  were  prepared
from protected L-cystine and L-homocystine derivatives,
respectively,  via  desulfurization  using  a  modified
literature procedure as shown in Scheme 2 [12]. Their
corresponding new di-NCAs (1c,  1e) were obtained by
phosgenation. While 1c was obtained in reasonable yield
(ca.  59%,  isolated  and  purified),  poor  solubility  of  L-
homolanthionine resulted in a low yield of 1e (ca. 12%,
isolated and purified). 
Scheme 2. Preparation of di-NCA monomers  1c (X= -SS-, Y= -S-)
and 1e (X= -CH2SSCH2-, Y= -CH2SCH2-).
With  di-NCAs  1a-1e in  hand,  we  prepared
copolypeptides of each of these with Bu-Glu NCA toward
the  goal  of  preparing  covalently  crosslinked  networks
[13].  tert-Butyl-L-glutamate  was  chosen  as  a  suitable
residue  to  form  soluble,  linear  polypeptide  segments
between  the  di--amino  acid crosslinks  [14].  After
removal  of  tert-butyl  protecting  groups,  L-glutamate
residues  also  provide  water  solubility  at  neutral  pH,
which should enable copolypeptide network swelling in
water to form hydrogels. Copolypeptides of Bu-Glu NCA
with each different di-NCA were prepared in THF using
KOtBu  initiator  (Scheme  3,  Table  1).  While  other
initiators, e.g. Co(PMe3)4, could be used to obtain living
NCA  copolymerizations  [15],  we  deemed  this
unnecessary  here  since  all  chains  were  ultimately
expected to be crosslinked into networks. Strongly basic
KOtBu initiator was chosen since it favors formation of
high  molecular  weight  copolymers  [16],  which  was
advantageous since long chain lengths were expected to
maximize the number of crosslinks per chain. The mole
percentage of  di-NCA in  copolymerizations was varied
from 1.0 to 5.0 % of total monomer content, and under
these  conditions  most  copolymerizations  went  to
complete consumption of  all  NCA monomers.  Notably,
the  copolymerizations  using  L-homolanthionine  di-NCA
w
ere  exceptions,  since  they  were  found  to  stop  with
considerable amounts of monomer remaining (ca. 30%).
Also,  at  higher  di-NCA  fractions,  small  amounts  of
copolypeptide  precipitation  was  observed  in  some
samples,  which  also  likely  limited  monomer
consumption. 
Scheme 3. Copolymerization of di-NCAs (1a-1e) with Bu-Glu NCA to
form  copolypeptide  networks.  y,z  =  mole  percent  of  each
comonomer. n = degree of polymerization.
Table 1. Copolymerization data for varying comonomer feed ratios. 
di-NCA
(mol %)
Bu-Glu
NCA
(mol %)
Yield (%)a
3a 3b 3c 3d
1.0 99.0 81 99 89 97
1.5 98.5 99 83 99 99
2.5 97.5 97 91 98 90
5.0 95.0 74 84b 93b 91
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[a]  Isolated  yield  of  deprotected  copolypeptides.  [b]  Incomplete
monomer consumption observed in copolymerization.
Scheme 4. Deprotection of copolymers to yield samples capable of
hydrogel  formation.  y,z  = mole percent  of  each comonomer.  n =
degree of polymerization. X = same as in Scheme 3.
All  the  copolypeptide  samples  (2a-2e)  prepared  in
Scheme 3 were found to form self-supporting organogels
in THF, with 2a-2d shown in Figure 3. These organogels
were stable against dilution confirming the formation of
crosslinked  networks  in  these  samples.  By  visual
inspection,  organogel  stiffness  for  all  samples  was
generally  observed  to  increase  with  increasing  mole
fraction of di-NCA, as would be expected for increased
crosslink  density.  After  removal  of  THF  from  these
samples  under  vacuum,  the  tert-butyl  groups  were
removed from L-glutamate residues by addition of TFA,
followed by neutralization with NaHCO3 and exhaustive
dialysis  against  DI  water  to  give  the  deprotected
copolypeptides as sodium salts (3a-3e) (Scheme 4).
Figure  3. Sample  images.  2a-2d)  4.0  wt%  organogels  formed
during  copolymerization  in  THF.  3a-3d)  Hydrogels  formed  from
copolymers at 1.0 wt% in DI H2O. 4a-4d) Network degradation after
exposure of copolymer networks (1.0 wt%) to TCEP for 48 hrs.
Addition  of  DI  water  to  samples  3a-3e resulted  in
swelling  of  the  copolypeptide  networks  and  hydrogel
formation. The samples from L-homolanthionine formed
only weak hydrogels (3e, Figures S1 and S2). Since the
compositions of these samples (3e) were not known due
to  incomplete  monomer  consumption,  more  detailed
analysis  of  their  properties  was  not  pursued.  With
sufficient  water  added  to  give  1.0  wt%  sample
concentrations,  all  of  the  remaining  copolypeptides
prepared  with  2.5  mole  percent  di-NCA  gave  self-
supporting hydrogels (Figure 3, Figure S3). Equilibrium
swelling  studies  of  samples  in  excess  DI  water  also
showed  that  hydrogel  swelling  ratio  was  inversely
correlated to crosslinker content, as would be expected
since crosslink density should increase with crosslinker
content (Figure S4, Table S1). An important observation
from this initial set of samples was that L-cystine was
the  least  effective  crosslinker  among the  different  di-
amino  acids  tested,  as  it  formed  the  most  fragile
hydrogels  (3a)  via  visual  inspection  (vide  infra).  In
contrast, samples prepared using all the other di-amino
acids formed hydrogels with much greater stiffness.
To  better  quantify  differences  in  hydrogel  properties
among different samples, we chose to compare samples
3a-3d, all containing 2.5 mole percent  di--amino acid
crosslinker.  Rheological  analysis  revealed  that  all  four
samples behaved as elastic hydrogels, as evidenced by
storage moduli (G') being greater than loss moduli (G")
over  a range of  frequency (Figure 4A).  The hydrogels
were found to  be somewhat brittle,  as  they  began to
break down at strain amplitudes of  ca. 10 (Figure 4B).
The  most  important  result  from  the  rheology
measurements was how hydrogel stiffness, as measured
by  G',  differed  as  a  function  of  di--amino  acid
crosslinker.  As  expected  from  visual  observations
discussed  above,  the  L-cystine  crosslinked  sample  3a
formed  the  weakest  hydrogel  (lowest  G'),  which  was
substantially weaker than all the others tested. The L-
homocystine  3b and  L-lanthionine  3c samples  gave
hydrogels with nearly an order of magnitude greater G'
compared  to  the  L-cystine  hydrogel  (Figure  4A).  The
sample containing L-cystathionine  3d gave the stiffest
hydrogel, which was more than twice as rigid as the 3b
and  3c hydrogels.  In  terms  of  efficiency  of  network
formation,  these data show that  L-cystine is  the least
efficient, and L-cystathionine is most efficient, in forming
covalent  copolypeptide  hydrogel  networks.  While
additional studies are needed to analyze these systems
in more detail, it is clear that small changes in di-NCA
tether  length  and  the  nature  of  the  tether  itself  (i.e.
thioether vs. disulfide) greatly impact the ability of the
di-NCA monomers to  form interchain  crosslinks during
copolymerization.
Figure 4. Rheology data for hydrogels 3a (●), 3b (♦), 3c (■), and
3d (▲) at 1.0 wt% in DI water. A) Frequency sweep experiments at
constant  strain  amplitude  of  0.1.  B)  Strain  sweep  experiments  at
constant  frequency  of  10  rad/s.  G′  =  solid  symbols;  G″  =  open
symbols.
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Scheme 5. Reduction of hydrogel networks with TCEP. y,z = mole
percent of each comonomer. n = degree of polymerization.
Beyond  their  utility  for  formation  of  copolypeptide
hydrogel  networks,  the  di--amino  acids  of  this  study
also  provide  chemical  functionality  that  can  impart
different  stimulus  responsive  properties  to  the
hydrogels. As a proof of concept, hydrogels 3a-3d were
subjected  to  chemical  reduction  using  tris-
carboxyethylphosphine  (TCEP)  in  aqueous  media
(Scheme  5).  TCEP  is  well  known  to  readily  reduce
disulfide  linkages  to  thiols,  but  should  not  reduce
thioether  linkages.  Upon  treatment  with  TCEP,  we
observed that disulfide crosslink containing samples 4a
and  4b became  free-flowing  liquids  (Figure  3),  which
confirmed that the  di--amino acids were acting as the
network crosslinks in the hydrogels and that these were
broken  upon  reduction.  As  expected,  the  thioether
crosslink  containing  hydrogels  4c and  4d were
unaffected  by  treatment  with  TCEP,  which  confirmed
that  these  linkages  were  resistant  to  cleavage  by
reduction.  These  different  responses  to  chemical
reduction provide a means to tune hydrogel properties
by choice of crosslinker. 
Conclusions
We have shown that biologically occurring non-canonical
di--amino  acids  can  be  converted  into  di-NCA
monomers in reasonable yields with high purity. While
di--amino acids are present in biology, the new di-NCA
monomers  reported here have never before been used
in the chemical synthesis of polypeptide biomaterials. In
order to evaluate structure-property effects of different
di--amino acid tethers on network properties, each di-
NCA was copolymerized with a monofunctional NCA to
obtain covalently crosslinked copolypeptides capable of
forming  hydrogels.  Notably,  use  of  widely  studied  L-
cystine di-NCA resulted in significantly weaker hydrogels
compared  to  the  di-NCAs  of  L-homocystine,  L-
cystathionine,  and  L-lanthionine,  suggesting  that  L-
cystine is likely not the best choice of di--amino acid for
preparation of copolypeptide networks. The di--amino
acid  crosslinkers  also  provided  different  chemical
stability,  where  disulfide  crosslinks  were  readily
degraded  by  reduction,  and  thioether  crosslinks  were
stable  against  reduction.  This  difference  in  reduction
response  may  provide  a  means  to  fine  tune  the
reduction  sensitivity  of  polypeptide  biomaterial
networks. 
This work exemplifies that  while readily  available  bio-
based  compounds  are  attractive  targets  for
biomaterials, there exists a greater palette of naturally
occurring  molecules  to  be  explored.  Such  compounds
can offer enhanced performance properties and may be
produced  through  advanced  microbial  engineering
technologies.  More  specifically,  we  have  shown  that
biological di--amino acid feedstocks can be converted
into monomers for preparation of covalently crosslinked
copolypeptide  networks  with  attractive  biomaterial
properties. These new building blocks thus expand the
design possibilities of novel functional biomaterials for
applications such as drug delivery, wound healing, and
tissue engineering.  
Experimental Section
Materials and Methods
TEA (Fisher) was distilled from CaH2 under N2 and stored
over  4  Å molecular sieves.  TMSCl  (Sigma-Aldrich) was
purified by distillation under N2. The following chemicals
were used as received from the vendor: trifluoroacetic
acid  (Oakwood),  L-cystine  dimethyl  ester  and  L-
homocystine  dimethyl  ester  (Chem-Impex  Intl.),
tris(diethylamino)-phosphine  (Sigma-Aldrich),
triphosgene  and  15%  phosgene  in  toluene  (Sigma-
Aldrich),  tris(carboxyethyl)phosphine  0.5  M  in  H2O
(Sigma-Aldrich). H2O was purified by reverse osmosis. L-
Homocysteine thiolactone hydrochloride [17], 3-chloro-L-
alanine  [18]  and  2  kDa  PEG-isocyanate  [19]  were
prepared  by  previously  reported  methods. NCA
purification  [20]  and  polymerizations  [15]  were
performed  in  an  N2  filled  glove  box  using  established
techniques.  Reactions  at  elevated  temperature  were
controlled  using  a  Corning  PC  420D  thermostated
hotplate equipped with  a  thermocouple probe.   Room
temperature  reactions  were  performed  at  ca.  22  ºC
ambient  temperature.  All  reactions  were  performed
under N2,  and unless otherwise described at 22 ºC.  THF
and hexanes were degassed by sparging with nitrogen
and dried by passage through columns of dried alumina.
Thin-layer chromatography was performed with EMD gel
60 F254 plates (0.25 mm thickness) and visualized using
a  UV  lamp  or  permanganate  stain.   Column
chromatography was performed using Silicycle Siliaflash
G60 silica (60-200 µm).  ESI-MS spectra were recorded
on a Waters LCT Premier spectrometer or a Q Exactive™
Plus  Hybrid  Quadrupole-Orbitrap™  Mass  Spectrometer.
FTIR  spectroscopy  was  performed  on  a  PerkinElmer
Spectrum  RX  spectrometer  or  a  JASCO  FT/IR-4100
spectrometer.  NMR spectroscopy was performed on a
Bruker  AV400 spectrometer.  Abbreviations:  acetic  acid
(AcOH),  attenuated  total  reflectance  infrared
spectroscopy  (ATR-IR),  chlorotrimethylsilane  (TMSCl),
circular  dichroism  (CD),  methoxy  polyethylene  glycol
(PEG),  molar  equivalent  (eq),  molecular  weight  cutoff
(MWCO), triethylamine (TEA), trifluoroacetic acid (TFA),
trifluoroacetic  anhydride  (TFAA),  trimethylsilyl  (TMS),
tetrahydrofuran  (THF),  tris(carboxyethyl)phosphine
(TCEP)
Synthetic Procedures
TFA-L-cystine-OMe  and  TFA-L-homocystine-OMe  were
prepared from commercially available L-cystine-OMe and
L-homocystine-OMe according to a literature procedure
[12].  TFA-L-lanthionine-OMe  was  prepared  from  TFA-L-
cystine-OMe according to a literature procedure [12].
TFA-L-homolanthionine-OMe
TFA-L-homocystine-OMe (0.60 g, 1.2 mmol, 1.0 eq) was
dissolved  in  anhydrous  benzene.
Tris(diethylamino)phosphine  (0.35  mL,  1.3  mmol,  1.05
eq) was added dropwise. The reaction was heated to 30
ºC and allowed to react for 16 hrs [20]. The reaction was
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cooled to room temperature and solvent was removed in
vacuo.  The  residue  was  purified  via  column
chromatography  (9:1  Hex:EtOAc  to  3:1  Hex:EtOAc)  to
yield TFA-L-homolanthionine-OMe as a white solid. (0.52
g. 94% yield). 
L-Lanthionine [12]
TFA-L-lanthionine-OMe (1.0  g,  2.3  mmol,  1.0  eq),  was
dissolved in THF (12 mL) and cooled to 0 ºC.  2N NaOH
(25  mL)  was  added  dropwise  and  the  reaction  was
allowed to  stir  for  1 hr  at  0 ºC.  1N HCl  (12 mL)  was
added and the mixture was adjusted to pH 6 with 1N
HCl. The solvent was removed in vacuo. The residue was
suspended in water and filtered to give L-lanthionine as
white crystals (0.27 g, 55% yield).  1H NMR (400 MHz,
TFA-D, 25 ºC):  4.69 (s, 2 H), 3.63-3.53 (m, 2H), 3.5-3.4
(m, 2H). 13C NMR (100 MHz, TFA-D, 25 ºC):  170.3, 53.0,
31.2. 
  
L-Homolanthionine [21] 
TFA-L-homolanthionine-OMe (0.56 g, 1.2 mmol, 1.0 eq),
was dissolved in THF (8 mL) and cooled to 0 ºC.   2N
NaOH (12 mL) was added dropwise and the reaction was
allowed to stir for 1 hr at 0 ºC. 1N HCl (6 mL) was added
and the mixture was adjusted to pH 6 with 1N HCl. The
solvent  was  removed  in  vacuo.  The  residue  was
dissolved in water (5 mL) and precipitated into absolute
ethanol (45 mL) and placed in the freezer overnight. The
reaction  was  centrifuged  and  the  supernatent  was
removed.  Excess  ethanol  was  removed  under  high
vacuum to yield white crystals (0.24 g, 81% yield).  1H
NMR (400 MHz, TFA-D, 25 ºC):  4.70 (q, J=6.0 Hz, 2 H),
3.00 (t, J=6.7 Hz, 2H), 2.67-2.45 (m, 4H).  13C NMR (100
MHz, TFA-D, 25 ºC):  172.7, 53.0, 28.3, 26.8. 
L-Cystathionine [11]
L-Homocystine  thiolactone-HCl (0.60  g,  3.9  mmol,  1.0
eq) and 3-chloro-L-alanine (0.63 g,  5.1  mmol,  1.3  eq)
were added to a flask and flushed with N2.  Degassed 5
N NaOH (3.5  mL,  18 mmol,  4.5  eq)  was added.   The
mixture was stirred for 64 h.  The pH was adjusted to
10.5-11.0 with conc. HCl(aq).  The mixture was cooled to 4
ºC and allowed to stand for 16 h.  The precipitate was
collected  by  vacuum  filtration.   The  amino  acid  was
recovered as a colorless solid (470 mg, 54% yield).   1H
NMR (400 MHz, D2O, 25 ºC):  4.30 (dd, J = 7.3, 4.5 Hz, 1
H), 4.20 (t, J = 6.5 Hz, 1 H), 3.25 (dd, J = 15.2, 4.6 Hz, 1
H), 3.15 (dd, J = 15.1, 7.2 Hz, 1 H), 2.80 (tm, J = 7.6 Hz,
2 H), 2.30 (m, 1 H), 2.21 (m, 1 H).   
L-Cystine di-NCA (1a)
L-Cystine (1.5 g, 6.2 mmol, 1.0 eq) was suspended in
THF (50 mL).  Triphosgene (2.5 g, 8.3 mmol, 1.3 eq) was
added in one portion.  The mixture was stirred at 50 ºC
for 24 h.  The turbid mixture was concentrated and the
crude product was purified by column chromatography
(50:50  THF:hexanes)  under  inert  atmosphere.   After
concentration,  the  material  was  diluted  with  THF  and
precipitated into hexanes.  This provided a pale yellow
solid (0.42 g, 23% yield).  The IR and  1H NMR for this
material  were  in  accordance  with  those  previously
reported [8-10].
     
L-Homocystine di-NCA (1b)
L-Homocystine (0.4 g, 1.5 mmol, 1.0 eq) was suspended
in THF (30 mL).  Triphosgene (0.59 g, 2.0 mmol, 1.3 eq)
was added in one portion.  The mixture was stirred at 50
ºC for 24 h.  The turbid mixture was concentrated and
the  crude  product  was  purified  by  column
chromatography  (60:40  THF:hexanes)  under  inert
atmosphere.   After  concentration,  the  material  was
diluted  with  THF  and precipitated  into  hexanes.   This
provided a colorless solid (0.20 g, 42% yield).  1H NMR
(400 MHz, CD3CN, 25 ºC): 6.87 (br s, 2 H), 4.47 (ddd, J
= 6.9, 5.4, 1.3 Hz, 2 H), 2.80 (t, J = 7.2 Hz, 4 H), 2.19 (m,
4 H).  13C NMR (100 MHz, CD3CN, 25 ºC): 172.1, 153.2,
57.5, 34.2, 31.8.  FTIR (thin film) 1860, 1792 cm-1 ESI-MS
m/z = 319.0063 [M-H]- (calcd 319.0059 for C10H11N2O6S2).
L-Lanthionine di-NCA (1c) 
L-Lanthionine (0.27 g, 1.3 mmol, 1.0 eq) was suspended
in THF (30 mL).  15% phosgene solution in toluene (3.6
mL, 5.1 mmol, 4 eq) was added.  The mixture was stirred
at 45 ºC for  18 h and then concentrated.   The crude
product was purified by column chromatography (60:40
THF:hexanes)  under  inert  atmosphere.   After
concentration,  the  material  was  diluted  with  THF  and
precipitated into hexanes.  This provided the product as
a white solid (0.20 g, 59% yield).   1H NMR (400 MHz,
CD3CN, 25 ºC):  6.84 (br s, 2 H), 4.62-4.58 (m, 2 H),
3.12-3.07 (dd, J = 4.0, 14.5 Hz, 2 H), 3.01-2.95 (m, 2H).
13C NMR (100 MHz,  CD3CN,  25 ºC):  169.51,  151.67,
58.4, 34.0.  FTIR (thin film) 1860, 1790 cm -1. ESI-MS m/z
= 259.0031 [M-H]- (calcd 259.0025 for C8H7N2O6S).  
   
L-Cystathionine di-NCA (1d)
L-Cystathionine (0.30  g,  1.3  mmol,  1.0  eq)  was
suspended in THF (20 mL).  15% phosgene solution (3.9
mL, 5.4 mmol, 4 eq) was added.  The mixture was stirred
at 45 ºC for  18 h and then concentrated.   The crude
product was purified by column chromatography (60:40
THF:hexanes)  under  inert  atmosphere.   After
concentration,  the  material  was  diluted  with  THF  and
precipitated  into  hexanes.   This  provided  a  colorless
solid (0.20 g, 54% yield).  1H NMR (400 MHz, CD3CN, 25
ºC):  6.86 (br m, 2 H), 4.62 (dd,  J = 4.2, 1.3 Hz, 1 H),
4.44 (dd, J = 1.4, 5.6 Hz, 1 H), 3.04 (dd, J = 14.5, 4.0 Hz,
1 H), 2.92 (dd, J = 14.5, 5.2 Hz, 1 H), 2.71 (t, J = 7.4 Hz,
2 H), 2.06 (m, 2 H).  13C NMR (100 MHz, CD3CN, 25 ºC):
170.9,  169.7,  151.8,  151.8,  58.2,  56.1,  32.4,  30.8,
28.0.  FTIR (thin film) 1860, 1792 cm-1.  ESI-MS  m/z =
273.0204 [M-H]- (calcd 273.0181 for C9H9N2O6S2).  
L-Homolanthionine di-NCA (1e)
L-Homolanthionine  (0.23  g,  1.0  mmol,  1.0  eq)  was
suspended in THF (30 mL). A solution of 15% phosgene
in toluene (2.8 mL, 4.0 mmol, 4 eq) was added.  The
mixture was stirred at 45 ºC for 24 h.  The turbid mixture
was concentrated and the crude product was purified by
column  chromatography  (60:40  THF:hexanes)  under
inert atmosphere.  After concentration, the material was
diluted  with  THF  and precipitated  into  hexanes.   This
provided a  sticky white solid  (0.03 g,  12% yield).   1H
NMR (400 MHz, CD3CN, 25 ºC):  6.87 (br s, 2 H), 4.47
(ddd, J = 6.9, 5.4, 1.3 Hz, 2 H), 2.80 (t, J = 7.2 Hz, 4 H),
2.19  (m,  4  H).   13C  NMR  (100  MHz,  CD3CN,  25  ºC):
171.0, 151.8, 56.2, 30.5, 26.3.  FTIR (thin film) 1856,
1788  cm-1.  ESI-MS  m/z =  287.0337  [M-H]-  (calcd
287.0338 for C10H11N2O6S).
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-tert-Butyl L-glutamate NCA (Bu-Glu NCA)
-tert-Butyl  L-glutamic  acid  (2.0  g,  9.8  mmol,  1.0  eq)
was suspended in THF (60 mL).  Triethylamine (2.75 mL,
19.7 mmol, 2.0 eq) and TMSCl (2.5 mL, 19.7 mmol, 2.0
eq) were added and the turbid mixture was stirred for
1hr  at  room temperature.  Phosgene  (15% in  toluene)
(10.2  mL,  14.7  mmol,  1.5  eq)  was  added  and  the
mixture was heated to 45 ºC and allowed to react for 2
hrs.  The turbid mixture was concentrated and the crude
product was purified by column chromatography (30:70
THF:Hexanes  to  50:50  THF:Hexanes)  under  inert
atmosphere.  After  concentration,  the  material  was
crystallized twice from 3:1 Hex:THF to provide a white
fluffy solid (1.75 g,  68%).  The IR and  1H NMR for this
material  were  in  accordance  with  those  previously
reported [14].
Binary copolymerizations of  di-NCAs with Bu-Glu
NCA
Separate stock solutions of each di-NCA (1a-1e) and Bu-
Glu NCA were prepared in THF (note that 3:1 THF:DMF
was required to dissolve 1c) at concentrations of 50 mg/
mL each.  These were mixed in different proportions to
obtain  the  desired  comonomer  feed  ratios.   The
resultant solutions were treated with a defined volume
of initiator (20 mg/mL solution of KOtBu in THF) to obtain
the  desired  monomer to  initiator  ratio.   The  mixtures
were  then  heated  at  40  ºC  for  24  h,  whereupon  all
samples formed organogels.  For each copolymerization,
an aliquot of the polymerization mixture was analyzed
by  FTIR  spectroscopy  to  determine  if  consumption  of
NCA monomers was complete.   The copolymerizations
were  then  concentrated  under  a  gentle  stream of  air
followed by high vacuum.  The obtained solids were then
carried  through  to  deprotection  without  further
purification.
Copolypeptide deprotection
Protected  copolypeptides  (2a-2e)  were  each  treated
with TFA (40 µL per mg of sample) and allowed to stand
for 24 h.  The mixtures were then evaporated under a
stream of air to provide solvent-swollen solids.  Volatiles
were  then  removed  under  high  vacuum.   The  crude
copolymer  networks  were  each  transferred  to  2  kDa
MWCO dialysis  bags and dialyzed against  aqueous 50
mM NaCl and 50 mM NaHCO3 (8h, 2 solvent changes)
followed  by  H2O  (16h,  3  solvent  changes).   The
retentates  were  then  lyophilized  to  provide  the
deprotected copolypeptide networks.
Preparation of Hydrogels
Deprotected  copolypeptide  networks  (3a-3e) were
swollen at 1 wt% concentration in DI H2O, sealed under
N2,  and centrifuged for  30 seconds to obtain hydrogel
samples.
Reduction of Hydrogels
Deprotected  copolypeptide  networks  (3a-3d) were
swollen at  1  wt% concentration in a  10mM NaOAc/10
mM TCEP aqueous solution, sealed under N2, and then
centrifuged to obtain hydrogel samples, which were let
stand for 12 h. Degradation of hydrogel networks was
determined via inversion of resulting samples (4a-4d).
Rheology
An Anton Paar MCR 102 rheometer with a 25 mm cone
and plate geometry and aqueous solvent trap was used
for all measurements. Frequency sweeps were measured
at  a  constant  strain  amplitude  of  0.1.  Strain  sweeps
were measured at a constant frequency of 10 rad/s. 
Equilibrium Hydrogel Swelling Experiments
Each  copolypeptide  network  sample  (3a-3d)  (~5mg)
was swollen in  excess (3  mL)  DI  H2O for 24 hours  at
room temperature. Excess water was wicked away and
the  mass  of  the  maximally  swollen  hydrogel  was
measured.
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